CUSIP: 07160F107
Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
6,277,081
-
Share change
-
+2,913,714
-
Total reported value
-
$6,336,848
-
Put/Call ratio
-
30%
-
Price per share
-
$1.01
-
Number of holders
-
32
-
Value change
-
+$453,806
-
Number of buys
-
21
-
Number of sells
-
13
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2021
-
Previous quarter:
Q3 2020
Recent filing periods for CUSIP 07160F107:
Institutional Holders of BAUDAX BIO INC - COM (BXRX) as of Q4 2020
As of 31 Dec 2020,
BAUDAX BIO INC - COM (BXRX) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,277,081 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GSA CAPITAL PARTNERS LLP, Brandywine Global Investment Management, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BlackRock Inc., D. E. Shaw & Co., Inc., TWO SIGMA INVESTMENTS, LP, and CITADEL ADVISORS LLC.
This page lists
32
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.